We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bipolar Sealing Device Offers More Uniform Tissue Compression

By HospiMedica International staff writers
Posted on 28 Jun 2011
An advanced bipolar sealing device delivers uniform compression across the entire length of the jaw, with a seal strength that withstands up to seven times normal systolic blood pressure.

The Enseal G2 Super Jaw is based on proprietary I-BLADE technology, designed for open surgical procedures such as colorectal, gynecological, and general surgery. More...
Based on advanced bipolar technology, the device delivers high uniform compression for sealing vessels consistently along the length of the 40 mm curved jaw. A polymer compound within the jaw uses positive temperature coefficient (PTC) technology to modulate energy flow, thus maintaining a constant temperature of approximately 100 °C, minimizing tissue sticking, charring, and smoke.

The jaws contain a temperature-sensitive matrix with embedded conductive carbon spherules designed to "sense" tissue characteristics. It uses extremely high jaw compression to create uniform tissue effects. In addition, the G2 Super Jaw's offset electrode design focuses and contains energy within the jaws, minimizing thermal spread to approximately one mm. The Enseal G2 Super Jaw is a product of Ethicon Endo-Surgery (Blue Ash, Cincinnati, OH, USA).

"Surgeons need to be able to control heat and have effective seal compression from their advance energy devices while at the same time respecting the tissue," said Professor of surgery Clyde Neal Ellis, MD, of Temple University (Philadelphia, PA, USA). "Until the Enseal G2 Super Jaw, this was not possible with large jaw energy devices. Surgeons now have a technology that is strong on providing consistent compression through the seal and is gentle on tissue; there is no longer a need to compromise."

Vessel sealing devices (VSDs) promise less blood loss, less surgical time, and improved efficiency, but also have potential complications. VSDs acts by low constant voltage, pulsed high current, and impedance feedback. With high coaptive pressure, 100% hydrogen cross-links are first ruptured in the blood vessel, forming a firm vascular seal.

Related Links:
Ethicon Endo-Surgery
Temple University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.